ストックスクリーナーアプリを入手
44.03
0.87%
0.36
前日終値:
$43.67
開ける：
$43.84
24時間の取引高:
57,517
Relative Volume:
0.08
時価総額：
$2.40B
収益：
$1.28B
当期純損益:
$-222.15M
株価収益率:
-10.77
EPS:
-4.09
ネットキャッシュフロー:
$145.52M
1週間 パフォーマンス:
+4.01%
1か月 パフォーマンス:
-3.72%
6か月 パフォーマンス:
-12.83%
1年 パフォーマンス:
-17.83%
1日の値動き範囲:
$43.69
$44.30
1週間の範囲:
$42.37
$44.30
52週間の値動き範囲:
$32.48
$57.35
Livanova Plc Stock (LIVN) Company Profile
LIVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
44.00 | 2.38B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
126.44 | 220.16B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.90 | 157.03B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.61 | 154.21B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.70 | 119.08B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.88 | 46.93B | 5.69B | 4.15B | 623.10M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
Why is LivaNova PLC stock attracting strong analyst attentionCapitalize on strong market momentum - jammulinksnews.com
What is LivaNova PLC company’s growth strategyRobust investment performance - jammulinksnews.com
Why LivaNova PLC stock attracts strong analyst attentionFree Stock Portfolio Optimization - Metal.it
What is the risk reward ratio of investing in LivaNova PLC stockMaximize your gains with professional insights - jammulinksnews.com
When is LivaNova PLC stock expected to show significant growthGet real-time alerts on top stocks - jammulinksnews.com
What makes LivaNova PLC stock price move sharplyFree Access to Community - beatles.ru
LivaNova’s VNS Therapy Shows Sustained Effectiveness in Drug-Resistant Epilepsy - Insider Monkey
Will LivaNova PLC stock benefit from interest rate changesFree Risk Assessment Services - jammulinksnews.com
How CPBI stock compares to its top competitorsIs LivaNova PLC stock undervalued or overvalued nowMarket-beating performance - jammulinksnews.com
Is LivaNova PLC a good long term investmentUnprecedented market success - PrintWeekIndia
What analysts say about LivaNova PLC stockMarket-leading capital gains - Autocar Professional
External Pacemakers Market Set to Witness Significant Growth - openPR.com
What drives LivaNova PLC stock priceBreakthrough financial growth - Autocar Professional
LivaNova PLC Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Cardiac Autonomic Control Market Growth in Future Scope - openPR.com
In-Line Blood Monitoring Devices Market is projected to grow - openPR.com
Wearable Cardioverter Defibrillators Market is projected - openPR.com
Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT - MSN
Neuro Modulation Devices Market is expected to reach US$ 7.6 - openPR.com
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
Livanova Plc (LIVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
10,938 |
| SCHERMERHORN TODD C | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
9,473 |
| KOZY WILLIAM A | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
4,840 |
0 |
33,148 |
| Barry James Christopher | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
4,772 |
| Story Brooke | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
6,892 |
| Enxing Seng Stacy | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
12,161 |
| WILVER PETER M | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
7,148 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '25 |
Option Exercise |
0.00 |
2,967 |
0 |
2,967 |
| Bolton Stephanie | President, Global Epilepsy |
Mar 30 '25 |
Option Exercise |
0.00 |
6,024 |
0 |
15,586 |
| Makatsaria Vladimir | Chief Executive Officer |
Mar 30 '25 |
Option Exercise |
0.00 |
9,330 |
0 |
9,330 |
1.15%
0.52%
大文字化:
|
ボリューム (24 時間):